HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Koichi Amano Selected Research

Koichi Amano Research Topics

Disease

30	Rheumatoid Arthritis 10/2015 - 12/2002
5	Infection 12/2014 - 12/2002
3	Lupus Nephritis 01/2013 - 01/2007
2	Vasculitis (Vasculitides) 01/2015 - 04/2005
2	Opportunistic Infections (Opportunistic Infection) 07/2013 - 12/2002
2	Fever (Fevers) 03/2012 - 09/2005
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2011 - 01/2007
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 09/2015
1	Neoplasms (Cancer) 01/2014
1	Acute Disease 01/2014
1	Pneumocystis Infections 07/2013
1	Hypersensitivity (Allergy) 07/2013
1	Latent Tuberculosis 07/2013
1	Hyperuricemia 01/2013
1	Arthralgia (Joint Pain) 03/2012
1	Adult-Onset Still's Disease 03/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Pneumonia (Pneumonitis) 10/2011
1	Drug Toxicity (Drug Safety) 10/2011
1	Portal Hypertension 09/2010
1	Sialadenitis 09/2010
1	Hyperglycemia 02/2009
1	Rheumatic Diseases (Rheumatism) 01/2009
1	Osteonecrosis (Kienbock's Disease) 01/2009
1	Congenital Abnormalities (Deformity) 07/2007
1	Hypertension (High Blood Pressure) 01/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2005
1	Dermatomyositis (Dermatopolymyositis) 09/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2005
1	Inflammation 04/2005
1	Osteoporosis 12/2002

Drug/Important Bio-Agent (IBA)

10	tocilizumab FDA Link 09/2015 - 01/2009
8	infliximab (Remicade)FDA Link 10/2015 - 01/2005
7	Methotrexate (Mexate)FDA LinkGeneric 09/2015 - 12/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2009
4	TNFR-Fc fusion protein (etanercept)FDA Link 10/2015 - 12/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 09/2005
4	abatacept (BELATACEPT)FDA Link 09/2015 - 09/2014
4	Interleukin-6 (Interleukin 6)IBA 05/2014 - 01/2009
3	GlucocorticoidsIBA 01/2015 - 01/2007
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2013 - 02/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013 - 12/2002
2	bredinin (mizoribine)IBA 11/2014 - 01/2013
2	Antirheumatic Agents (DMARD)IBA 07/2014 - 01/2006
2	Prednisolone (Predate)FDA LinkGeneric 01/2009 - 09/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2007 - 09/2005
2	bucillamine (SA 96)IBA 01/2006 - 01/2005
1	CytokinesIBA 10/2015
1	AntigensIBA 07/2013
1	polyglucosanIBA 07/2013
1	Interferon-gamma (Interferon, gamma)IBA 07/2013
1	Tuberculin (PPD)IBA 07/2013
1	EnzymesIBA 01/2013
1	adalimumab (Humira)FDA Link 06/2012
1	Ferritins (Ferritin)IBA 03/2012
1	Biological Markers (Surrogate Marker)IBA 03/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 09/2010
1	ametantrone (HAQ)IBA 08/2010
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 08/2010
1	Recombinant ProteinsIBA 03/2009
1	Monoclonal AntibodiesIBA 03/2009
1	Etidronic Acid (HEDP)FDA LinkGeneric 01/2009
1	Antihypertensive Agents (Antihypertensives)IBA 01/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2007
1	Penicillamine (Cuprimine)FDA Link 01/2006
1	Antinuclear AntibodiesIBA 09/2005
1	glucuronyl glucosamine glycan sulfate (Vessel)IBA 04/2005
1	SteroidsIBA 12/2002

Therapy/Procedure

1	Retreatment 01/2014
1	Biological Therapy 11/2012